Clinical Trial Update: Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and efficacy of ambrisentan for diastolic heart failure (heart failure with preserved ejection fraction) in pulmonary hypertensi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Pulmonary Hypertension

Drugs mentioned

• Ambrisentan (Ambrisentan)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction | Phase 4 | Status: TERMINATED | Results posted: 2019-05-22